What Is eXoZymes Inc. (EXOZ) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, eXoZymes Inc. presents a highly debated valuation profile at its current price of $6.12. The composite intrinsic value is estimated at $6.23 (+1.7% average upside), masking a wide model spread between the 3 bullish models and 3 bearish models. Model dispersion is worth noting: First Chicago targets $13.58 (+121.9%), versus Dynamic NAV at $0.27 (-95.6%). This +217.5% range highlights the importance of multi-model analysis rather than relying on any single methodology.
What Do the Models Say About EXOZ?
6 of 13 models are currently active for EXOZ. Of these, 3 models suggest upside while 3 models suggest overvaluation. The Bayesian DCF estimates EXOZ's intrinsic value at $2.09, implying -65.8% downside from the current price. See which stocks rank higher →
How Does EXOZ Rank in Biological Products, (No Diagnostic Substances)?
Among 134 Biological Products, (No Diagnostic Substances) stocks, EXOZ ranks #82 by Quality of Company score. CirclFi's QOC score of 4.9/10 evaluates 32 fundamental signals. A score of 4.9 reflects mixed fundamentals.
See all Most Undervalued Biological Products, (No Diagnostic Substances) Stocks →
eXoZymes Inc. operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.
Is EXOZ a Value Trap?
The Value Trap algorithm is not active for EXOZ. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
6 of 13 models are active for eXoZymes Inc.. Moderate coverage provides meaningful perspective. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi Deep Alpha Valuation Engine, eXoZymes Inc. scores 4.9 out of 10 on our 32-signal quality assessment, a moderate rating that shows mixed signals across our quality framework with notable weaknesses. The QOC score synthesizes profitability margins, revenue growth reliability, debt management, and capital allocation into a single metric designed to separate durable businesses from statistically cheap ones.
The gap between the most bullish and bearish model spans +217.5% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every EXOZ valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across EXOZ's 6 active models, average confidence is 20%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad